Drug Shortage Report for ACTEMRA
Report ID | 156092 |
Drug Identification Number | 02483327 |
Brand name | ACTEMRA |
Common or Proper name | ACTEMRA |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TOCILIZUMAB |
Strength(s) | 162MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | Autoinjector |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-04-30 |
Actual start date | 2022-05-09 |
Estimated end date | |
Actual end date | 2022-12-06 |
Shortage status | Resolved |
Updated date | 2022-12-07 |
Company comments | Due to ongoing global product constraint, orders containing this product will be fulfilled based on current supply. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2022-12-07 | French | Compare |
v17 | 2022-12-07 | English | Compare |
v16 | 2022-07-21 | French | Compare |
v15 | 2022-07-21 | English | Compare |
v14 | 2022-07-21 | French | Compare |
v13 | 2022-07-21 | English | Compare |
v12 | 2022-06-15 | French | Compare |
v11 | 2022-06-15 | English | Compare |
v10 | 2022-05-10 | English | Compare |
v9 | 2022-05-09 | French | Compare |
v8 | 2022-05-09 | English | Compare |
v7 | 2022-05-01 | English | Compare |
v6 | 2022-04-12 | French | Compare |
v5 | 2022-04-12 | English | Compare |
v4 | 2022-03-31 | French | Compare |
v3 | 2022-03-31 | English | Compare |
v2 | 2022-03-04 | French | Compare |
v1 | 2022-03-04 | English | Compare |
Showing 1 to 18 of 18